Cargando…
Regulation of Kinase Signaling Pathways by α6β4-Integrins and Plectin in Prostate Cancer
SIMPLE SUMMARY: α6β4-integrins and plectin are the key structural components of hemidesmosomes that have been implicated in carcinogenesis and which are thus considered as potential cancer biomarkers and drug targets for anti-cancer therapies. In this review, we elaborate on the current knowledge of...
Autores principales: | Koivusalo, Saara, Schmidt, Anette, Manninen, Aki, Wenta, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818203/ https://www.ncbi.nlm.nih.gov/pubmed/36612146 http://dx.doi.org/10.3390/cancers15010149 |
Ejemplares similares
-
Loss of α6β4 Integrin-Mediated Hemidesmosomes Promotes Prostate Epithelial Cell Migration by Stimulating Focal Adhesion Dynamics
por: Schmidt, Anette, et al.
Publicado: (2022) -
Disassembly of α6β4-mediated hemidesmosomal adhesions promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin to focal adhesions
por: Wenta, Tomasz, et al.
Publicado: (2022) -
Binding of Integrin α6β4 to Plectin Prevents Plectin Association with F-Actin but Does Not Interfere with Intermediate Filament Binding
por: Geerts, Dirk, et al.
Publicado: (1999) -
α6β1- and αV-integrins are required for long-term self-renewal of murine embryonic stem cells in the absence of LIF
por: Cattavarayane, Sandhanakrishnan, et al.
Publicado: (2015) -
Plectin protects podocytes from adriamycin‐induced apoptosis and F‐actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway
por: Ni, Yongliang, et al.
Publicado: (2018)